Serevent

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Aktīvā sastāvdaļa:

Salmeterol xinafoate 36.3ug equivalent to to 25 µg Salmeterol base per acuation;  

Pieejams no:

GlaxoSmithKline NZ Limited

SNN (starptautisko nepatentēto nosaukumu):

Salmeterol xinafoate 36.3 µg (Equiv. to 25 µg Salmeterol base per acuation)

Deva:

25 mcg/dose

Zāļu forma:

Aerosol inhaler, metered dose

Kompozīcija:

Active: Salmeterol xinafoate 36.3ug equivalent to to 25 µg Salmeterol base per acuation   Excipient: Dichlorodifluoromethane Lecithin Trichlorofluoromethane

Vienības iepakojumā:

Inhaler, metered, 120 dose, Sample pack, 1 U

Klase:

Prescription

Receptes veids:

Prescription

Ražojis:

Glaxo Wellcome Manufacturing Pte Ltd

Produktu pārskats:

Package - Contents - Shelf Life: Inhaler, metered, - 60 dose units - 24 months from date of manufacture stored at or below 30°C - Inhaler, metered, Sample pack - 120 dose units - 24 months from date of manufacture stored at or below 30°C - Inhaler, metered, - 120 dose units - 24 months from date of manufacture stored at or below 30°C

Autorizācija datums:

1992-03-26